Supernus Pharmaceuticals SUPN Business Segments — Other segment items
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Supernus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.
The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Supernus Pharmaceuticals's business segments — other segment items.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Supernus Pharmaceuticals's business segments — other segment items?
- Supernus Pharmaceuticals (SUPN) reported business segments — other segment items of $22M in Q1 2026.
- How has Supernus Pharmaceuticals's business segments — other segment items changed year-over-year?
- Supernus Pharmaceuticals's business segments — other segment items decreased by 24.2% year-over-year, from $29.02M to $22M.
- What is the long-term trend for Supernus Pharmaceuticals's business segments — other segment items?
- Over 3 years (2022 to 2025), Supernus Pharmaceuticals's business segments — other segment items has grown at a 10.5% compound annual growth rate (CAGR), from $67.53M to $91.14M.
- What does business segments — other segment items mean?
- Captures miscellaneous operational costs or income items that do not fall into standard expense categories. Monitoring this helps identify non-recurring or unique financial impacts affecting the segment's overall performance.